Stereotaxis Inc. (NSDQ:STXS) said it plans to raise $14.6 million through a public offering.
The St. Louis, Mo.-based cardiology instrument maker said the company will use the proceeds to support sales, marketing and clinical support efforts in addition to research and development and general corporate purposes.